HISTIDINE & FERROUS IONS NEW TYPE OF OXYGEN CARRIER FOR THALASSEMIA PATIENTS

In thalassemia, a genetic mutation disrupts the production of hemoglobin, the vital protein in red blood cells responsible for carrying oxygen. This defect leads to the creation of abnormal hemoglobin molecules that are unstable and prone to breaking down. Consequently, the red blood cells are fragile, short-lived, and cannot effectively pick up or transport oxygen throughout the body. This fundamental failure in oxygen delivery results in the symptoms of anemia, such as fatigue and shortness of breath. Histidine, an amino acid commonly found in the active sites of proteins like hemoglobin, plays a crucial role in binding an iron ion (Fe²⁺). This histidine-iron complex is then able to bind molecular oxygen (O₂). The process typically involves the Fe²⁺ ion, which is coordinative unsaturated, meaning it has an open binding site. The O₂ molecule then binds directly to this available site on the iron, forming a coordinate covalent bond. In many biological systems, the oxygen binding event triggers a subtle change in the geometry of the iron atom, pulling the histidine residue and the surrounding protein structure, a key step in facilitating oxygen transport.